clinical trial · NCT06315322
A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
UCB Biopharma SRL·phase3·recruiting·n = 120
Childhood Absence EpilepsyJuvenile Absence EpilepsyBrivaracetam Film-coated tabletBrivaracetam oral solution
brief summary
The purpose of the study is to investigate the long-term safety and tolerability of brivaracetam in study participants with childhood absence epilepsy or juvenile absence epilepsy.
started
Jul 10, 2024
primary completion
Mar 1, 2030
completion
Mar 1, 2030
last updated
Apr 13, 2026
official title
A MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE LONG-TERM SAFETY AND TOLERABILITY OF BRIVARACETAM IN STUDY PARTICIPANTS WITH CHILDHOOD ABSENCE EPILEPSY OR JUVENILE ABSENCE EPILEPSY
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol